CSOP SEA TECH ETF(USD)
π΄π²Oman
Clinical Trials
46
Active:1
Completed:20
Trial Phases
6 Phases
Early Phase 1:2
Phase 1:1
Phase 2:3
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (37 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
22 (59.5%)Phase 4
5 (13.5%)Phase 3
4 (10.8%)Phase 2
3 (8.1%)Early Phase 1
2 (5.4%)Phase 1
1 (2.7%)Effect of Smartphone Application (MED-AD) on Medication Adherence Among Patients With Cardiovascular Disease in Oman
Not Applicable
Not yet recruiting
- Conditions
- Ischemic Cardiovascular DiseaseHypertensionHyperlipidemia
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Sultan Qaboos University
- Target Recruit Count
- 1000
- Registration Number
- NCT06951451
- Locations
- π΄π²
Ministry of Health, Muscat, Oman
Enhancing Life Quality in Community-Dwelling Older Omanis by Telling Their Life Story
Not Applicable
Completed
- Conditions
- Healthy Older Adults
- First Posted Date
- 2025-03-18
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Sultan Qaboos University
- Target Recruit Count
- 75
- Registration Number
- NCT06881914
- Locations
- π΄π²
Sultan Qaboos University Hospital, Muscat, Oman
Effective of Transcranial Magnetic Stimulation (TMS) vs Treatment as Usual for First-Episode Depression in Adults
Phase 4
Not yet recruiting
- Conditions
- Major Depressive Disorder
- Interventions
- Device: Transcranial magnetic stimulation
- First Posted Date
- 2024-10-16
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Sultan Qaboos University
- Target Recruit Count
- 120
- Registration Number
- NCT06644833
Central Venous Catheter-Related Thrombosis in Critically Ill Patients
Completed
- Conditions
- Catheter Related Complication
- First Posted Date
- 2024-08-27
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Sultan Qaboos University
- Target Recruit Count
- 315
- Registration Number
- NCT06573112
- Locations
- π΄π²
Sultan Qaboos University Hospital, Muscat, Oman
The Use of Melatonin for Delirium Prevention in Medically Hospitalized Patients
Phase 2
Recruiting
- Conditions
- Delirium
- Interventions
- Drug: Intervention 2Drug: Intervention 1Other: Control
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Sultan Qaboos University
- Target Recruit Count
- 240
- Registration Number
- NCT06509191
- Locations
- π΄π²
Sultan Qaboos University Hospital, Muscat, Oman
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
News
Oman Achieves Medical Milestone with First Successful CAR-T Cell Therapy Implementation
The University Medical City in Oman successfully implemented the first CAR-T cell therapy in the Sultanate, positioning the country among regional leaders in advanced blood cancer treatment.